{"id":"W2958648554","doi":"10.1186/s40425-019-0662-5","title":"The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)","year":2019,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":738,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"National Center for Advancing Translational Sciences; University of Texas MD Anderson Cancer Center; National Institute for Health and Care Research; Cancer Research UK; Yale University; Society for Immunotherapy of Cancer; Università degli Studi di Milano; Brigham and Women's Hospital; Yale Cancer Center; Memorial Sloan-Kettering Cancer Center","keywords":"Pembrolizumab; Medicine; Nivolumab; Head and neck squamous-cell carcinoma; Oncology; Internal medicine; Immunotherapy; Cancer; Head and neck cancer; Population","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01135711,0.001807164,0.002517219,0.002422689,0.001782246,0.005030993,0.004121441,0.009889809,0.01092841],"category_scores_gemma":[0.01289982,0.0008665551,0.002514828,0.003331433,0.001523753,0.002489641,0.004934921,0.01390953,0.01450715],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004541694,"about_ca_system_score_gemma":0.0236294,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005512808,"about_ca_topic_score_gemma":0.009769385,"domain_scores_codex":[0.989902,0.003092772,0.000909292,0.0006622847,0.004283715,0.00114982],"domain_scores_gemma":[0.9817842,0.00152181,0.002472159,0.0006777036,0.01052734,0.003016762],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009909927,0.0001063569,0.0003724275,0.001190059,0.00007245432,0.00008471811,0.00006212976,0.0002561285,0.000836784,0.002607798,0.8801046,0.1142074],"study_design_scores_gemma":[0.0001117854,0.0001217493,0.0006203785,0.00102867,0.00004833971,0.0002310976,0.00004111998,0.000116195,0.0002817533,0.001234195,0.9961457,0.00001908695],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.003419832,0.3094409,0.01030069,0.3505876,0.1683646,0.002906078,0.007953015,0.001528193,0.145499],"genre_scores_gemma":[0.02199531,0.4441702,0.03303759,0.227615,0.05898445,0.00875379,0.03698345,0.000975058,0.1674851],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.01135711,"threshold_uncertainty_score":0.06006289,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02314064955390921,"score_gpt":0.3334324786407749,"score_spread":0.3102918290868656,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}